LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 98 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2018. The put-call ratio across all filers is 2.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $200,000 | -94.9% | 46,880 | -89.0% | 0.00% | -100.0% |
| Q3 2019 | $3,920,000 | -0.5% | 425,579 | -0.1% | 0.01% | 0.0% |
| Q2 2019 | $3,939,000 | +72.0% | 425,799 | +19.5% | 0.01% | +50.0% |
| Q1 2019 | $2,290,000 | -32.4% | 356,199 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $3,387,000 | -43.5% | 356,199 | +19.6% | 0.01% | -33.3% |
| Q3 2018 | $5,996,000 | -19.3% | 297,859 | +17.0% | 0.01% | -18.2% |
| Q2 2018 | $7,427,000 | +22.8% | 254,609 | +25.4% | 0.01% | +22.2% |
| Q1 2018 | $6,048,000 | -0.3% | 203,089 | +8.7% | 0.01% | +12.5% |
| Q4 2017 | $6,064,000 | -3.0% | 186,889 | +4.0% | 0.01% | -11.1% |
| Q3 2017 | $6,252,000 | +2400.8% | 179,760 | +1608.7% | 0.01% | – |
| Q3 2016 | $250,000 | – | 10,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 4,138,893 | $123,256,000 | 18.11% |
| Broadfin Capital, LLC | 1,656,720 | $49,337,000 | 7.69% |
| SECTORAL ASSET MANAGEMENT INC | 1,128,219 | $33,598,000 | 3.68% |
| Perceptive Advisors | 4,313,611 | $128,459,000 | 3.60% |
| RTW INVESTMENTS, LP | 1,122,540 | $33,429,000 | 3.18% |
| Asymmetry Capital Management, L.P. | 55,864 | $1,664,000 | 2.08% |
| EMORY UNIVERSITY | 77,335 | $2,303,000 | 1.64% |
| Monashee Investment Management LLC | 185,000 | $5,509,000 | 1.52% |
| SPHERA FUNDS MANAGEMENT LTD. | 260,000 | $7,743,000 | 1.18% |
| Stanley-Laman Group, Ltd. | 167,825 | $4,998,000 | 1.14% |